Table 1: Study population demographic characteristics and indications for prescribing aminoglycosides.
|
Characteristic |
Gentamicin (n=132) Number (%) |
Amikacin (n=68) Number (%) |
Total (n=200) Number (%) |
|
Average age (years) |
9.86 |
4.16 |
7.87 |
|
Age groups |
|
|
|
|
<1 month |
34 (25.8%) |
46 (67.6%) |
80 (40%) |
|
> 1 month and ≤ 24 months |
40 (30.3%) |
12 (17.6%) |
52 (26%) |
|
>24 months and <18 years |
41 (31%) |
6 (8.8%) |
47 (23.5%) |
|
≥18 years |
17 (12.9%) |
4 (5.9%) |
21 (10.5%) |
|
Ideal body weight in kg (Mean ± SD) |
16.83±20.4 |
9.21±18.43 |
14.24±20 |
|
Aminoglycoside prescribed |
132 (66.0%) |
68 (34.0%) |
200 (100.0%) |
|
Indication for aminoglycoside |
|
|
|
|
Neonatal sepsis |
|
|
78 (39%) |
|
Infantile sepsis |
|
|
28 (14%) |
|
Urinary tract infection |
|
|
26 (13%) |
|
Sepsis |
|
|
25 (12.5%) |
|
Pneumonia |
|
|
15 (7.5%) |
|
Infective endocarditis |
|
|
8 (4%) |
|
Surgical wound infection |
|
|
7 (3.5%) |
|
Meningitis |
|
|
6 (3%) |
|
Febrile neutropenia |
|
|
5 (2.5%) |
|
Diabetic septic foot |
|
|
2 (1%) |